May v. SmithKline Beecham Clinical Laboratories, Inc.

710 N.E.2d 460, 304 Ill. App. 3d 242, 237 Ill. Dec. 830, 1999 Ill. App. LEXIS 244
CourtAppellate Court of Illinois
DecidedApril 14, 1999
Docket5-98-0428
StatusPublished
Cited by36 cases

This text of 710 N.E.2d 460 (May v. SmithKline Beecham Clinical Laboratories, Inc.) is published on Counsel Stack Legal Research, covering Appellate Court of Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
May v. SmithKline Beecham Clinical Laboratories, Inc., 710 N.E.2d 460, 304 Ill. App. 3d 242, 237 Ill. Dec. 830, 1999 Ill. App. LEXIS 244 (Ill. Ct. App. 1999).

Opinion

JUSTICE CHAPMAN

delivered the opinion of the court:

Plaintiff, Martha Ann May, filed a putative class action lawsuit against defendant, SmithKline Beecham Clinical Laboratories, Inc. (SBCL), based upon SBCL’s alleged improper billing for medical laboratory tests. SBCL sought to have plaintiffs case stayed pursuant to section 2—619(a)(3) of the Civil Practice Law (735 ILCS 5/2—619(a)(3) (West 1996)) because eight other putative class actions are pending against SBCL across the country. The trial court denied SBCL’s motion to stay, and SBCL filed this interlocutory appeal pursuant to Supreme Court Rule 307(a)(1) (166 Ill. 2d R. 307(a)(1)). We affirm for the reasons set forth below.

BACKGROUND

In 1997, a settlement agreement between SBCL and the United States government was made public. The settlement agreement resulted from qui tarn (“whistleblower”) lawsuits filed on behalf of the government against SBCL. The agreement required SBCL to pay $325 million in restitution for improper medical claims submitted and paid under government health plans. The settlement agreement did not provide for restitution to be made to the following: members (i.e., patients) of the government health plans for co-payments made, private third-party payers or their members, or patients who directly paid for the medical services provided by SBCL. As a result of the settlement agreement, this case and eight other putative class action lawsuits, which claimed damages from improper billing practices, were filed on behalf of patients who paid SBCL either directly or under a co-payment agreement with their insurance. Additionally, two smaller putative class actions have been filed (one on behalf of certain employee benefit plans and the other on behalf of certain New York patients). Finally, in September 1997, a nonclass action case, with 37 insurance companies as named plaintiffs, was filed against SBCL in a federal district court in Connecticut.

This case was the sixth putative class action case to be filed. Out of the nine lawsuits filed, all but this case have been either filed in or transferred by the Judicial Panel on Multidistrict Litigation to the United States District Court for the District of Connecticut, where the cases have been consolidated and pretrial proceedings are being conducted under the designation of “MDL-1210,” entitled “In re SmithKline Beecham Clinical Laboratories, Inc. Laboratory Test Billing Practices Litigation.'”

In each of the nine class action suits filed, the putative plaintiffs’ lawsuits were based on SBCL’s settlement agreement with the United States government, and most of the putative class actions filed recite the same “overall scheme” used by SBCL to implement the improper billing practices. SBCL’s “scheme” allegedly involves the following improper billing practices: (1) add-ons, i.e., billing for tests not ordered by physicians, (2) unbundling, i.e., billing separately for tests that should have been billed at a single composite rate, (3) double billing, i.e., billing twice for the same test, (4) up-coding, i.e., performing and billing for more expensive tests' than ordered, and (5) code-jamming, i.e., inserting fabricated diagnosis codes to obtain reimbursement from third-party payers.

The bases of the various causes of action stated in the complaints are as follows: violation of the Racketeer Influenced and Corrupt Organizations Act (18 U.S.C. § 1961 et seq. (1994)), violation of the Employee Retirement Income Security Act (29 U.S.C. § 1001 et seq. (1994)), federal and state common law claims for unjust enrichment and restitution, negligence, breach of contract, violation of Pennsylvania’s Unfair Trade Practices and Consumer Protection Law (Pa. Stat. Ann. tit. 73, § 201—1 et seq. (West 1993)), conversion, fraud, violation of Illinois’s Consumer Fraud and Deceptive Business Practices Act (815 ILCS 505/1 et seq. (West 1996)), and violation of Florida’s Deceptive and Unfair Practices Act (Fla. Stat. Ann. § 501.201 et seq. (West 1997)). The putative class actions filed primarily seek money damages for payments made by plaintiffs, although certain cases also seek injunctive relief. Plaintiff in this case claims that no federal question is raised on her pleadings. However, the same claim was made by plaintiffs in two of the other pending cases, one of which was filed in Cook County, Illinois. These other two cases have been transferred to the federal district court in Connecticut.

FACTS

Plaintiff filed this putative class action on December 27, 1997. Plaintiff asserted the following causes of action against SBCL: (1) violation of the Illinois Consumer Fraud and Deceptive Business Practices Act, (2) unjust enrichment or restitution, (3) fraud, and (4) breach of contract.

After plaintiff successfully defeated SBCL’s attempt to remove this case to federal court, SBCL filed a motion to dismiss for the failure to state a cause of action, pursuant to section 2—615 of the Civil Practice Law (735 ILCS 5/2—615 (West 1996)), and a motion to dismiss or stay pursuant to section 2—619(a)(3) of the Civil Practice Law (735 ILCS 5/2—619(a)(3) (West 1996)). In support of SBCL’s motion to dismiss or stay the proceedings, SBCL filed an affidavit and attached as exhibits the other pending complaints filed against it. Both parties filed two memoranda in support of their positions on these motions. On July 2, 1998, the trial court denied SBCL’s motions. This interlocutory appeal followed.

ANALYSIS

SBCL contends that the trial court abused its discretion when it denied SBCL’S motion to stay proceedings pursuant to section 2—619(a)(3). SBCL argues that it proved that duplicative actions were pending between the same parties for the same cause and that it proved that the other four factors to be considered when determining whether to grant a motion for a stay weighed heavily in its favor. These factors are comity; the prevention of multiplicity, vexation, and harassment; the likelihood of obtaining complete relief in the foreign jurisdiction; and the res judicata effect of a foreign judgment in the local forum.

Plaintiff argues that the court’s ruling was proper because defendant has not overcome the substantial presumption of propriety afforded the trial court’s discretion in ruling on the motion, because the record does not show that the court failed to consider the four factors which are to be weighed in determining defendant’s motion to stay; that the four factors are not necessarily dispositive of the motion; and that plaintiff will be significantly harmed if defendant’s motion is granted.

Section 2—619(a)(3) provides that a defendant may move for dismissal “or other appropriate relief’ if another pending action involving the same parties for the same cause exists. 735 ILCS 5/2—619(a)(3) (West 1996).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Riaz v. Northwestern Memorial Hospital
2025 IL App (1st) 241203-U (Appellate Court of Illinois, 2025)
First American Properties & Acquisitions, Inc. v. Harry Oil, LLC
2025 IL App (1st) 221941-U (Appellate Court of Illinois, 2025)
Bridgeton Landfill, LLC v. Continental Casualty Company
2024 IL App (1st) 231949-U (Appellate Court of Illinois, 2024)
Copper Bend Pharmacy, Inc. v. Optum Rx, Inc.
2021 IL App (5th) 210083-U (Appellate Court of Illinois, 2021)
Pace Communications Services Corp. v. Express Products, Inc.
2014 IL App (2d) 131058 (Appellate Court of Illinois, 2014)
Pace Communications Services Corporation
2014 IL App (2d) 131058 (Appellate Court of Illinois, 2014)
Cholipski v. Bovis Lend Lease, Inc.
2014 IL App (1st) 132842 (Appellate Court of Illinois, 2014)
Marzouki v. Najar-Marzouki
2014 IL App (1st) 132841 (Appellate Court of Illinois, 2014)
Van Der Hooning v. Board of Trustees of the University of Illinois
2012 IL App (1st) 111531 (Appellate Court of Illinois, 2012)
Aventine Renewable Energy, Inc. v. JP Morgan Securities, Inc.
940 N.E.2d 257 (Appellate Court of Illinois, 2010)
Whittmanhart, Inc. v. CA, INC.
932 N.E.2d 520 (Appellate Court of Illinois, 2010)
Whittmanhart v. CA, Inc.
Appellate Court of Illinois, 2010
Continental Casualty Co. v. Radio Materials Corp.
851 N.E.2d 857 (Appellate Court of Illinois, 2006)
Allianz Insurance v. Guidant Corp.
839 N.E.2d 113 (Appellate Court of Illinois, 2005)
Allianz Insurance Co. v. Guidant Corp.
Appellate Court of Illinois, 2005
Doe v. Chand
781 N.E.2d 340 (Appellate Court of Illinois, 2002)
Doe v. Chand Corrected Opinion
Appellate Court of Illinois, 2002

Cite This Page — Counsel Stack

Bluebook (online)
710 N.E.2d 460, 304 Ill. App. 3d 242, 237 Ill. Dec. 830, 1999 Ill. App. LEXIS 244, Counsel Stack Legal Research, https://law.counselstack.com/opinion/may-v-smithkline-beecham-clinical-laboratories-inc-illappct-1999.